S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
Log in

Avacta Group Share Price, Forecast & Analysis (LON:AVCT)

GBX 20.25
+0.25 (+1.25 %)
(As of 11/18/2019 04:00 PM ET)
Today's Range
19.20
Now: GBX 20.25
20.25
50-Day Range
15.25
MA: GBX 17.86
20.50
52-Week Range
15.03
Now: GBX 20.25
49.80
Volume231,965 shs
Average Volume19,964 shs
Market Capitalization£35.63 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. It operates through two segments, Life Sciences and Animal Health. The company's custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development. In addition, it provides tools and contract services to assist the diagnosis of conditions in animals to enable treatment for veterinarians. Read More…

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1904-217070

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£4.12 million
Cash FlowGBX 6.57 per share
Book ValueGBX 20.80 per share

Profitability

Miscellaneous

Employees114
Market Cap£35.63 million
Next Earnings DateN/A
OptionableNot Optionable

Receive AVCT News and Ratings via Email

Sign-up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter.


Avacta Group (LON:AVCT) Frequently Asked Questions

What is Avacta Group's stock symbol?

Avacta Group trades on the London Stock Exchange (LON) under the ticker symbol "AVCT."

How were Avacta Group's earnings last quarter?

Avacta Group Plc (LON:AVCT) posted its quarterly earnings results on Tuesday, April, 9th. The biotechnology company reported ($4.80) EPS for the quarter. View Avacta Group's Earnings History.

Has Avacta Group been receiving favorable news coverage?

Headlines about AVCT stock have been trending very negative recently, InfoTrie reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Avacta Group earned a news impact score of -3.0 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Avacta Group.

Who are some of Avacta Group's key competitors?

What other stocks do shareholders of Avacta Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avacta Group investors own include Skinbiotherapeutics (SBTX), Augean (AUG), 7Digital Group (7DIG), Bunzl (BNZL), ReNeuron Group (RENE), Countrywide (CWD), Coro Energy (CORO), Communisis (CMS), Bahamas Petroleum (BPC) and Best of the Best (BOTB).

Who are Avacta Group's key executives?

Avacta Group's management team includes the folowing people:
  • Prof. Alastair Smith, CEO & Exec. Director
  • Mr. Tony Gardiner, CFO, Company Sec. & Exec. Director (Age 48)
  • Dr. Michael Albin, Adviser
  • Dr. Matt Johnson, Chief Technology Officer
  • Dr. Amrik Basran Ph.D., Chief Scientific Officer

How do I buy shares of Avacta Group?

Shares of AVCT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Avacta Group's stock price today?

One share of AVCT stock can currently be purchased for approximately GBX 20.25.

How big of a company is Avacta Group?

Avacta Group has a market capitalization of £35.63 million and generates £4.12 million in revenue each year. Avacta Group employs 114 workers across the globe.View Additional Information About Avacta Group.

What is Avacta Group's official website?

The official website for Avacta Group is http://www.avacta.com/.

How can I contact Avacta Group?

Avacta Group's mailing address is Unit 20, Ash Way, WETHERBY, LS23 7FA, United Kingdom. The biotechnology company can be reached via phone at +44-1904-217070.


MarketBeat Community Rating for Avacta Group (LON AVCT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  203 (Vote Outperform)
Underperform Votes:  191 (Vote Underperform)
Total Votes:  394
MarketBeat's community ratings are surveys of what our community members think about Avacta Group and other stocks. Vote "Outperform" if you believe AVCT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVCT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Featured Article: Diluted Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel